Diseases, Conditions, Syndromes

WHO hosts special meeting on worrying new COVID-19 variant

Advisers to the World Health Organization are holding a special session Friday to flesh out information about a worrying new variant of the coronavirus that has been detected in South Africa, though a top expert says its ...

Vaccination

EU regulator authorizes Pfizer's COVID vaccine for kids 5-11

The European Union's drug regulator on Thursday authorized Pfizer's coronavirus vaccine for use on children from 5 to 11 years old, clearing the way for shots to be administered to millions of elementary school pupils amid ...

Diseases, Conditions, Syndromes

EU drug agency starts evaluating new COVID-19 treatment

The European Union's medicines authority said Thursday that it is evaluating a new drug for treating COVID-19 patients who do not require extra oxygen but are at increased risk of developing severe symptoms of the disease.

Vaccination

Novavax asks EU drug regulator to OK its COVID vaccine

The European Union's drug regulator said it received an application from Novavax to authorize the American biotechnology company's coronavirus vaccine, a request that could significantly boost the continent's vaccine supplies ...

Diseases, Conditions, Syndromes

EU drug agency looking at data on Merck's COVID-19 pill

The European Union's medicines agency on Monday began reviewing Merck's COVID-19 treatment pill so that it can swiftly advise national drug authorities in the 27-nation bloc that want to begin using it before it gets official ...

Medical economics

COVID-19: Governments must stop vaccine cost secrecy

Globally affordable COVID-19 vaccines will not be accessible until governments stop allowing vaccine companies to keep their manufacturing costs secret, according to a new paper published by the Journal of the Royal Society ...

Vaccination

Indonesia first to greenlight Novavax COVID-19 vaccine

Biotechnology company Novavax said Monday that Indonesia has given the world's first emergency use authorization for its COVID-19 vaccine, which uses a different technology than current shots.

Vaccination

Valneva reports 'positive' COVID vaccine results

Franco-Austrian biotech lab Valneva announced Monday positive results from clinical trials of its COVID vaccine candidate, a month after the UK government terminated a supply deal with the company.

page 11 from 40